Menu Search
Equities

Naturhouse Health SA

2NH:DUS

Naturhouse Health SA

Actions
  • Price (EUR)1.52
  • Today's Change-0.02 / -1.30%
  • Shares traded-1.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Jun 03 2024 15:00 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Naturhouse Health SA is a Spain-based company primarily engaged in the special foods and wellbeing products manufacture. The Company specializes in developing, manufacturing and selling products within the nutrition, as well as weight management sector. Its activities are divided into three business areas: Food Supplements, which provides products with natural extracts to facilitate the slimming process; Healthy Foods and Drinks, which offers dietary snacks and meals for breakfast; as well as Cosmetics and Body Care, which includes cosmetics for skin treatment during the slimming process. The Company distributes products through a network of own and franchised stores. Furthermore, It operates in Spain, France, Poland, Italy, Mexico, the United Kingdom, and Canada, among others. The Company is a subsidiary of Kiluva SA, as well as controls a number of entities, such as SAS Naturhouse, Kiluva Diet SLU, Zamodiet Mexico SA de CV and Naturhouse Sp z o o.

  • Revenue in EUR (TTM)50.41m
  • Net income in EUR11.29m
  • Incorporated--
  • Employees207.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.